High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$20.5M
$20,505,154
Total Sells (Filtered)
$0
$0
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
CADL
P
Candel Therapeutics, Inc.
Manning Paul B
• Director
Discretionary BuyΔOwn +24.9%
2026-02-23
$2,999,996Large
|
||||||
| CADL |
Candel Therapeutics, Inc.
|
Director
Discretionary BuyΔOwn +24.9%
|
2026-02-23 | $2,999,996Large | P | Form 4 |
|
VRCA
P
Verrica Pharmaceuticals Inc.
Manning Paul B
• Director
Discretionary BuyΔOwn +53.2%
2025-11-25
$5,835,050Whale
|
||||||
| VRCA |
Verrica Pharmaceuticals Inc.
|
Director
Discretionary BuyΔOwn +53.2%
|
2025-11-25 | $5,835,050Whale | P | Form 4 |
|
VRCA
P
Verrica Pharmaceuticals Inc.
Manning Paul B
• Director
Discretionary BuyΔOwn +460.3%
2025-11-25
$11,670,108MEGA
|
||||||
| VRCA |
Verrica Pharmaceuticals Inc.
|
Director
Discretionary BuyΔOwn +460.3%
|
2025-11-25 | $11,670,108MEGA | P | Form 4 |